Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Allergen immunotherapy in polysensitized patient

M. Hrubiško, V. Špičák,

. 2016 ; 48 (3) : 69-76.

Jazyk angličtina Země Itálie

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc18034133

Specific allergen immunotherapy (AIT) is the only therapeutic method with positive impact on natural course of allergic disease - affecting clinical development (including the progression of rhinitis to asthma) and new sensitisations. The actual problem is the increasing number of patients manifesting poly-sensitivity in allergy skin tests and / or in specific IgE tests. Usually, AIT is not recommended in such individuals. The objective we are facing is that in many patients tested as poly-reactive, we have to distinguish in which cases it is a true polysensitization, and when it is due to cross-reactivity of specific IgE antibodies induced by panallergens. This may really determine when AIT may be an appropriate course of action. The article focuses on this problem in more detail, applying the long time Czech and Slovak experience with allergy testing and allergen immunotherapy.

000      
00000naa a2200000 a 4500
001      
bmc18034133
003      
CZ-PrNML
005      
20191112134913.0
007      
ta
008      
181008s2016 it f 000 0|eng||
009      
AR
035    __
$a (PubMed)27152601
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a it
100    1_
$a Hrubiško, M $u Dept. Allergy & Clinical Immunology, Oncology Institute St. Elisabeth, Batislava, Slovakia. OKIA OÚSA, Heydukova 10 85103 Batislava, Slovakia Phone: +42 190 34 16 121 E-mail: martin.hrubisko@ousa.sk; mahrubisko@gmail.com.
245    10
$a Allergen immunotherapy in polysensitized patient / $c M. Hrubiško, V. Špičák,
520    9_
$a Specific allergen immunotherapy (AIT) is the only therapeutic method with positive impact on natural course of allergic disease - affecting clinical development (including the progression of rhinitis to asthma) and new sensitisations. The actual problem is the increasing number of patients manifesting poly-sensitivity in allergy skin tests and / or in specific IgE tests. Usually, AIT is not recommended in such individuals. The objective we are facing is that in many patients tested as poly-reactive, we have to distinguish in which cases it is a true polysensitization, and when it is due to cross-reactivity of specific IgE antibodies induced by panallergens. This may really determine when AIT may be an appropriate course of action. The article focuses on this problem in more detail, applying the long time Czech and Slovak experience with allergy testing and allergen immunotherapy.
650    _2
$a alergeny $7 D000485
650    _2
$a bronchiální astma $7 D001249
650    _2
$a zkřížené reakce $7 D003429
650    12
$a desenzibilizace imunologická $7 D003888
650    _2
$a lidé $7 D006801
650    _2
$a kožní testy $7 D012882
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Špičák, Václav, $d 1929-2019 $7 jn19981002473 $u Immuno-Flow, Praha, Czech Republic.
773    0_
$w MED00196633 $t European annals of allergy and clinical immunology $x 1764-1489 $g Roč. 48, č. 3 (2016), s. 69-76
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27152601 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20181008 $b ABA008
991    __
$a 20191112135150 $b ABA008
999    __
$a ok $b bmc $g 1341037 $s 1031127
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 48 $c 3 $d 69-76 $i 1764-1489 $m European annals of allergy and clinical immunology $n Eur Ann Allergy Clin Immunol $x MED00196633
LZP    __
$a Pubmed-20181008

Najít záznam

Citační ukazatele

Možnosti archivace